Efficacy of Azithromycin in Treatment of Acne Vulgaris: A Mini Review
- PMID: 31309049
- PMCID: PMC6620802
- DOI: 10.29252/wjps.8.2.127
Efficacy of Azithromycin in Treatment of Acne Vulgaris: A Mini Review
Abstract
Background: Antibiotics are commonly used in the treatment of acne vulgaris. Considering the rise of antibiotic resistance, alternative medications may be used in the main anti-acne armamentarium. The aim of this study was to investigate the efficacy of oral azithromycin in the treatment of acne vulgaris.
Methods: Database searches were performed in PubMed and Scopus using the keywords "azithromycin" and "acne".
Results: Azithromycin 500 mg once daily for 3 days per week or in cycles of 10 days for 12 weeks are the most commonly used regimens.
Conclusion: Available experimental data suggest that oral azithromycin is an effective and well-tolerated option for treatment of acne vulgaris.
Keywords: Acne vulgaris; Azithromycin; Doxycycline; Tetracycline; Treatment.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age?J Dermatolog Treat. 2011 Aug;22(4):206-10. doi: 10.3109/09546631003762639. Epub 2010 Jul 29. J Dermatolog Treat. 2011. PMID: 20666686 Clinical Trial.
-
Comparison of the Efficacy of Azithromycin Versus Doxycycline in Acne Vulgaris: A Meta-Analysis of Randomized Controlled Trials.Ann Dermatol. 2018 Aug;30(4):417-426. doi: 10.5021/ad.2018.30.4.417. Epub 2018 Jun 28. Ann Dermatol. 2018. PMID: 30065581 Free PMC article.
-
Azithromycin versus tetracycline in the treatment of acne vulgaris.J Dermatolog Treat. 2006;17(4):217-21. doi: 10.1080/09546630600866459. J Dermatolog Treat. 2006. PMID: 16971315 Clinical Trial.
-
Common and alternate oral antibiotic therapies for acne vulgaris: a review.J Drugs Dermatol. 2007 Sep;6(9):873-80. J Drugs Dermatol. 2007. PMID: 17941358 Review.
-
Oral Antibiotic Treatment Options for Acne Vulgaris.J Clin Aesthet Dermatol. 2020 Sep;13(9):26-32. Epub 2020 Sep 1. J Clin Aesthet Dermatol. 2020. PMID: 33133338 Free PMC article. Review.
Cited by
-
Decoding Acne Vulgaris: Insights into Pathogenesis, Treatment Modalities, Diagnosis and Recent Advancements.Recent Adv Inflamm Allergy Drug Discov. 2025;19(1):18-30. doi: 10.2174/0127722708312980240718093537. Recent Adv Inflamm Allergy Drug Discov. 2025. PMID: 40195701 Review.
-
Recent Advances Regarding the Therapeutic Potential of Adapalene.Pharmaceuticals (Basel). 2020 Aug 28;13(9):217. doi: 10.3390/ph13090217. Pharmaceuticals (Basel). 2020. PMID: 32872149 Free PMC article. Review.
-
Efficacy of Topical Treatments in the Management of Mild-to-Moderate Acne Vulgaris: A Systematic Review.Cureus. 2024 Apr 9;16(4):e57909. doi: 10.7759/cureus.57909. eCollection 2024 Apr. Cureus. 2024. PMID: 38725769 Free PMC article. Review.
-
Going, Toll-like receptors in skin inflammation and inflammatory diseases.EXCLI J. 2021 Jan 7;20:52-79. doi: 10.17179/excli2020-3114. eCollection 2021. EXCLI J. 2021. PMID: 33510592 Free PMC article. Review.
-
Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study.ACS Omega. 2022 Oct 25;7(44):39782-39793. doi: 10.1021/acsomega.2c03762. eCollection 2022 Nov 8. ACS Omega. 2022. PMID: 36385887 Free PMC article.
References
-
- Dawson AL, Dellavalle RP. Acne vulgaris. BMJ. 2013;346:f2634. - PubMed
-
- Rzany B, Kahl C. [Epidemiology of acne vulgaris] J Dtsch Dermatol Ges. 2006;4:8–9. - PubMed
-
- Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379:361–72. - PubMed
-
- Magin P, Pond D, Smith W, Watson A. A systematic review of the evidence for ‘myths and misconceptions’ in acne management: diet, face-washing and sunlight. Fam Pract. 2005;22:62–70. - PubMed
Publication types
LinkOut - more resources
Full Text Sources